Abstract
The aim of this study is to substantiation the impact of C3, C4 in patients with Systemic lupus erythematosus. During the period 2/January/2019 to 1/October/2020, thirty three patients (32femal: 1male) with Systemic lupus erythematosus that diagnosed by specialist with ages ranged between (15-60) years, by using C3, C4 immunturbidimetric test. of all patient, 33% have low level of serum C3, 12% have low level of serum C4.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
